Genetic tests showed that certain patients were predisposed to brain injuries if they took the drugs. That information remained secret. Alzheimer’s Disease, Drugs (Pharmaceuticals), Brain, Leqembi (Drug), Genetics and Heredity, Clinical Trials, Hemorrhagic Stroke, Retirement Communities and Assisted Living, Elderly, Medicine and Health, Alzheimer’s Assn, Amgen Inc, Banner Alzheimer’s Institute, Biogen Inc, Eisai Co Ltd, Eli Lilly and Company, Food and Drug Administration, Government Accountability Office, Institute for Clinical and Economic Review, Novartis AG, Kisunla, Villages, The (Fla), United States Genetic tests showed that certain patients were predisposed to brain injuries if they took the drugs. That information remained secret. NYT > Business
What Drugmakers Did Not Tell Volunteers in Alzheimer’s Trials
